Preinterventional pan-immune-inflammation value as a tool to predict postcontrast acute kidney injury among acute coronary syndrome patients implanted drug-eluting stents: a retrospective observational study.
Postcontrast acute kidney injury
acute coronary syndrome
pan-immune-inflammation value
percutaneous coronary intervention
Journal
Scandinavian journal of clinical and laboratory investigation
ISSN: 1502-7686
Titre abrégé: Scand J Clin Lab Invest
Pays: England
ID NLM: 0404375
Informations de publication
Date de publication:
20 Mar 2024
20 Mar 2024
Historique:
medline:
20
3
2024
pubmed:
20
3
2024
entrez:
20
3
2024
Statut:
aheadofprint
Résumé
We evaluated the value of pan-immune-inflammation value (PIV) in predicting the risk for postcontrast acute kidney injury (PCAKI), an important complication following percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS) patients. Medical records of 839 ACS patients underwent PCI between June 2019 and December 2022 were retrospectively analyzed. Patients were divided into two groups: PCAKI (-) and PCAKI (+). PCAKI was defined as
Identifiants
pubmed: 38506475
doi: 10.1080/00365513.2024.2330904
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM